UK markets close in 1 hour 32 minutes

Vivoryon Therapeutics N.V. (0R3M.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
18.83+0.30 (+1.62%)
As of 12:16PM BST. Market open.
Full screen
Previous close18.53
Open18.94
Bid0.00 x 0
Ask0.00 x 0
Day's range18.63 - 18.94
52-week range18.63 - 18.94
Volume1,057
Avg. volumeN/A
Market cap245.916M
Beta (5Y monthly)1.75
PE ratio (TTM)N/A
EPS (TTM)-0.83
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Vivoryon Therapeutics N.V.: Vivoryon Therapeutics Provides Update on Financial Guidance

    DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous29.06.2021 / 01:11 The issuer is solely responsible for the content of this announcement.Vivoryon Therapeutics Provides Update on Financial GuidanceHalle (Saale) / Munich, Germany, June 29, 2021 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines, today announced an update on its financial guidance. A

  • EQS Group

    Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China

    DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Agreement29.06.2021 / 01:03 The issuer is solely responsible for the content of this announcement.Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater ChinaHalle (Saale)/Munich, Germany and Nanjing, China, June 29, 2021 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) a clinical-sta

  • EQS Group

    Vivoryon Therapeutics N.V.: Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V.

    DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): AGM/EGM28.06.2021 / 18:00 The issuer is solely responsible for the content of this announcement. Ordinary General Meeting of Shareholders of Vivoryon Therapeutics N.V. HALLE (SAALE) / MUNICH, GERMANY, June 28, 2021 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon) a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines today announced, that its shareholders approved a